Voyager Therapeutics, Inc. - 8-K Filing

Voyager Therapeutics presented favorable GLP toxicology data for VY1706 at Alzheimer’s Association International Conference on July 13, 2026. (Items: 8.01 Other Events)

SEC EDGAR ·

Tickers: $VYGR

Read the full article at SEC EDGAR

More Regulatory news